Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2007 2
2008 1
2009 3
2010 2
2011 3
2012 2
2013 1
2014 1
2016 3
2017 2
2018 3
2019 4
2020 1
2021 3
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondria and Sex-Specific Cardiac Function.
Vona R, Ascione B, Malorni W, Straface E. Vona R, et al. Among authors: ascione b. Adv Exp Med Biol. 2018;1065:241-256. doi: 10.1007/978-3-319-77932-4_16. Adv Exp Med Biol. 2018. PMID: 30051389 Review.
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2.
Abbruzzese C, Matteoni S, Matarrese P, Signore M, Ascione B, Iessi E, Gurtner A, Sacconi A, Ricci-Vitiani L, Pallini R, Pace A, Villani V, Polo A, Costantini S, Budillon A, Ciliberto G, Paggi MG. Abbruzzese C, et al. Among authors: ascione b. Cell Death Dis. 2023 Dec 13;14(12):821. doi: 10.1038/s41419-023-06353-3. Cell Death Dis. 2023. PMID: 38092755 Free PMC article.
α-Adrenoceptor stimulation attenuates melanoma growth in mice.
Maccari S, Buoncervello M, Ascione B, Stati T, Macchia D, Fidanza S, Catalano L, Matarrese P, Gabriele L, Marano G. Maccari S, et al. Among authors: ascione b. Br J Pharmacol. 2022 Apr;179(7):1371-1383. doi: 10.1111/bph.15731. Epub 2022 Jan 26. Br J Pharmacol. 2022. PMID: 34766341 Free article.
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.
Fragale A, Stellacci E, Romagnoli G, Licursi V, Parlato S, Canini I, Remedi G, Buoncervello M, Matarrese P, Pedace L, Ascione B, Pizzi S, Tartaglia M, D'Atri S, Presutti C, Capone I, Gabriele L. Fragale A, et al. Among authors: ascione b. Int J Cancer. 2023 Sep 1;153(5):1080-1095. doi: 10.1002/ijc.34602. Epub 2023 Jun 9. Int J Cancer. 2023. PMID: 37293858
38 results